Bo Carlberg

7PUBLICATIONS
17CO-AUTHORS
Traditional Chinese medicine and treatmentsMedical biotechnology diagnostics (incl. biosensors)Epidemiological modellingBehavioural epidemiologyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 23, 2025
Beliefs about medicines in relation to the initiation of cardiovascular preventive medications during a 3 year follow-up period after inclusion in the VIPVIZA trial: a cohort study.

Eva Sönnerstam, Henrik Holmberg, Bo Carlberg

|Dec 04, 2023
Reconstituted and frozen botulinum toxin A is as effective and safe as fresh for treating axillary hyperhidrosis: A retrospective study.

Alexander Shayesteh, Antonia Boman, Emil Hawas

|Aug 03, 2022
Time to initiation of lipid-lowering drugs for subclinical atherosclerosis: sub-study of VIPVIZA randomized controlled trial, with single-arm cross-over.

Henrik Holmberg, Maria Sjölander, Eva-Lotta Glader

|Apr 08, 2022
Survival after surgery of the ascending aorta: a matched cohort study.

Linn Skoglund Larsson, Johan Ljungberg, Lars Johansson

|Feb 18, 2022
Association of education and feedback on hypertension management with risk for stroke and cardiovascular disease.

Mattias Brunström, Nawi Ng, John Dahlström

|Dec 30, 2021
Methodological Aspects of Meta-Analyses Assessing the Effect of Blood Pressure-Lowering Treatment on Clinical Outcomes.

Mattias Brunström, Costas Thomopoulos, Bo Carlberg

Pageof 2

Frequent Collaborators

3 joint publications

Mattias Brunström

3 joint publications

Margareta Norberg

2 joint publications

Anders Själander

2 joint publications

Eva-Lotta Glader